Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The RECENSUS Study: A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)

NCT02231697 is registered in ClinicalTrials.gov with Astellas Gene Therapies as lead sponsor.

NCT NCT02231697
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02231697 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The RECENSUS Study: A Medical Chart Review of Patients With X-Linked Myotubular Myopathy (XLMTM)
Lead sponsor
Astellas Gene Therapies
Phase
Observational
Overall status
Completed
Start date
September 30, 2014
Completion date
December 31, 2019
Enrollment
161 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

males with x-linked myotubular myopathy (xlmtm)